PMCF Study of Debridement Pad

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAdvanced Medical Solutions Ltd.

About this trial

The design of the study is a clinical trial of Debridement Pad in subjects with superficial, chronic and acute wounds consisting of Diabetic ulcers, Arterial and Venous Leg ulcers, Pressure ulcers, Postoperative wounds healing by secondary intention, traumatic or surgical wounds and burns and scalds. The performance data from this study will support clinically meaningful rates of successful improvement in wound bed condition immediately after treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Males or females aged 18 years or above.

Patients who can understand and give informed consent to take part in the study.

Have one or more of the following wounds: Diabetic ulcers, Arterial and Venous Leg ulcers, Pressure ulcers, Postoperative wounds healing by secondary intention, traumatic and surgical wounds, and burns and scalds

Wounds that require debridement due to the presence of slough debris/fibrous tissue ,hyperkeratotic debris and dried exudate on the peri wound skin.

Disqualifiers

Patients who are known to be non-compliant with medical treatment

Patients who are known to be sensitive to any of the device components such as polyester.

Subject has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with their ability to participate in the study.

Subject is currently enrolled in another clinical study, or has completed a clinical study less than 30 days prior to enrolment.

Trial design

Design model

Single group

Treatments tested in this trial

  • Debridement Pad

    Device

    Study device

Treatment groups

184 Participants
are divided into 1 treatment group
Group A: InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Performance of the Debridement Pad

Performance of the Debridement Pad on Diabetic ulcers, Arterial and Venous Leg ulcers, Pressure ulcers, Postoperative wounds healing by secondary intention, traumatic and surgical wounds, and burns and scalds. Success will be determined by the following: 1\. Change of wound bed condition from baseline (pre debridement) to assessment immediately after the use of the debridement pad as defined as a. Percentage reduction of wound coverage of visible debris/necrosis/slough from the wound bed at baseline assessment and after procedure.

Time frame
From baseline to immediately after treatment

Secondary outcomes

1

Safety by adverse events

Safety will be evaluated as incidence of device-related adverse events

Time frame
From baseline to immediately after treatment
2

Time recorded for procedure

Time recorded for the debridement procedure

Time frame
From baseline to immediately after treatment
3

Removal of debris

Debris/necrosis/slough absorbed/ removed by the Debridement pad.

Time frame
From baseline to immediately after treatment
4

Pain during procedure

Pain during the debridement procedure time frame assessed after procedure using the Visual Analogue scale.

Time frame
From baseline to immediately after treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.